Accelerate Diagnostics, Inc.
AXDX US00430H2013
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.
Annual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
-35% | -86% | -33% | -72% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Phillips Jack CEO |
0.65 USD |
25,343 Sold |
16,473 USD |
04/04/2025 | 04/04/2025 |
Mertz Larry Michael CTO |
0.65 USD |
1,523 Sold |
990 USD |
04/04/2025 | 04/04/2025 |
Patience David CFO |
0.71 USD |
6,816 Sold |
4,839 USD |
01/04/2025 | 01/04/2025 |
Patience David CFO |
1.09 USD |
535 Sold |
583 USD |
26/02/2025 | 26/02/2025 |
Phillips Jack CEO |
1.35 USD |
485 Sold |
655 USD |
01/02/2025 | 03/02/2025 |
Schuler Jack W O |
1.57 USD |
200,000 Sold |
314,000 USD |
03/12/2024 | 03/12/2024 |
Patience John O |
1.57 USD |
200,000 Bought |
314,000 USD |
03/12/2024 | 03/12/2024 |
Mertz Larry Michael CTO |
0.88 USD |
275 Sold |
242 USD |
20/05/2024 | 20/05/2024 |
Mertz Larry Michael CTO |
0.88 USD |
86 Sold |
76 USD |
20/05/2024 | 20/05/2024 |
Phillips Jack CEO |
0.78 USD |
26,735 Sold |
20,853 USD |
17/04/2024 | 17/04/2024 |